Mirxes Holding Company Company Description

Mirxes Holding Company Limited, a micro ribonucleic acid technology company, provides diagnostic solutions for the screening of cancer, cardiovascular, metabolic, and infectious diseases accessible across Singapore and China.

The company offers GASTROClear, a blood-based miRNA detection panel consisting of 12 miRNA biomarkers for gastric cancer screening; LUNGClear, a lung cancer screening product candidate; and Fortitude COVID-19 RT-qPCR test kits.

It also researches, develops, and manufactures biotechnology, life, and medical science related products.

The company was founded in 2014 and is headquartered in Singapore.

Mirxes Holding Company Limited

Country	Cayman Islands
Founded	2014
Industry	Biotechnology
Sector	Healthcare
Employees	352
CEO	Lihan Zhou

Contact Details

Address: 2 Tukang Innovation Grove Singapore, 618305 Singapore
Phone	65 6816 2931
Website	mirxes.com

Stock Details

Ticker Symbol	2629
Exchange	Hong Kong Stock Exchange
Fiscal Year	January - December
Reporting Currency	USD
SIC Code	3841

Key Executives

Name	Position
Dr. Ruiyang Zou Ph.D.	Co-Founder, Deputy Chief Executive Officer, Chief Technology Officer and Executive Director
Dr. Lihan Zhou Ph.D.	Co-Founder, Chief Executive Officer and Executive Director
Hou Chiat Ho	Chief Investment Officer and Executive Director
Beng Lor Choo CPA	Chief Financial Officer
Wei Zhi Owyong	Joint Company Secretary
Yuet Chew Siow	Joint Company Secretary